NERV (Minerva Neurosciences) Cyclically Adjusted Book per Share: $9.59 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NERV Minerva Neurosciences Inc NERV
34 GF Score
Price $4.48
! 1 Warning Sign
View Full Analysis

What is Minerva Neurosciences Cyclically Adjusted Book per Share?

Minerva Neurosciences NERV -1.75% 34 Cyclically Adjusted Book per Share is $9.59 as of Jun. 2026. GuruFocus rates NERV with a GF Score™ of 34/100. The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Minerva Neurosciences's adjusted book value per share for the three months ended in Jun. 2026 was $-4.516. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $9.59 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Minerva Neurosciences's average Cyclically Adjusted Book Growth Rate was -23.80% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -14.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Minerva Neurosciences was -14.70% per year. The lowest was -14.70% per year. And the median was -14.70% per year.

As of today (2026-09-01), Minerva Neurosciences's current stock price is $4.48. Minerva Neurosciences's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was $9.59. Minerva Neurosciences's Cyclically Adjusted PB Ratio of today is 0.47.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Minerva Neurosciences was 0.48. The lowest was 0.00. And the median was 0.00.


Minerva Neurosciences  (NAS:NERV) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Minerva Neurosciences's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=4.48/9.59
=0.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Minerva Neurosciences was 0.48. The lowest was 0.00. And the median was 0.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Minerva Neurosciences Cyclically Adjusted Book per Share Related Terms


Minerva Neurosciences Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Minerva Neurosciences's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Minerva Neurosciences Cyclically Adjusted Book per Share Chart

Minerva Neurosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 17.97 16.55 14.07 11.14

Minerva Neurosciences Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.59 11.86 11.14 10.55 9.59

NERV vs GLSI, TNXP, RNA: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Minerva Neurosciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Minerva Neurosciences Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Minerva Neurosciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Minerva Neurosciences's Cyclically Adjusted PB Ratio falls into.


NERV
34GF Score
Minerva Neurosciences Inc NERV
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Minerva Neurosciences Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Minerva Neurosciences's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-4.516/333.9520*333.9520
=-4.516

Current CPI (Jun. 2026) = 333.9520.

Minerva Neurosciences Quarterly Data

Book Value per Share CPI Adj_Book
201609 26.003 241.428 35.968
201612 24.208 241.432 33.485
201703 23.166 243.801 31.732
201706 22.392 244.955 30.527
201709 26.907 246.819 36.406
201712 27.167 246.524 36.802
201803 25.040 249.554 33.508
201806 22.845 251.989 30.276
201809 20.880 252.439 27.622
201812 18.546 251.233 24.652
201903 15.872 254.202 20.851
201906 13.790 256.143 17.979
201909 11.383 256.759 14.805
201912 5.686 256.974 7.389
202003 3.799 258.115 4.915
202006 11.207 257.797 14.518
202009 10.878 260.280 13.957
202012 9.862 260.474 12.644
202103 8.497 264.877 10.713
202106 6.773 271.696 8.325
202109 5.258 274.310 6.401
202112 1.494 278.802 1.790
202203 -0.138 287.504 -0.160
202206 -1.570 296.311 -1.769
202209 -2.668 296.808 -3.002
202212 -3.750 296.797 -4.219
202303 -4.985 301.836 -5.515
202306 -1.789 305.109 -1.958
202309 -2.867 307.789 -3.111
202312 -4.069 306.746 -4.430
202403 -5.232 312.332 -5.594
202406 -6.362 314.175 -6.762
202409 -3.099 315.301 -3.282
202412 -3.674 315.605 -3.888
202503 -4.168 319.799 -4.352
202506 -4.592 322.561 -4.754
202509 -4.945 324.800 -5.084
202512 -3.252 324.054 -3.351
202603 -5.794 330.213 -5.860
202606 -4.516 333.952 -4.516

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $9.59 mean?
Minerva Neurosciences (NERV) has a Cyclically Adjusted Book per Share of $9.59 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Minerva Neurosciences and its competitors.
Is Minerva Neurosciences' Cyclically Adjusted Book per Share too high?
Minerva Neurosciences' current Cyclically Adjusted Book per Share is $9.59. Overall, Minerva Neurosciences has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Minerva Neurosciences' Cyclically Adjusted Book per Share compare to GLSI and TNXP?
Minerva Neurosciences' Cyclically Adjusted Book per Share of $9.59 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Minerva Neurosciences and its competitors. Minerva Neurosciences's current Cyclically Adjusted Book per Share is $9.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Minerva Neurosciences stock overvalued right now?
Minerva Neurosciences (NERV) has a current Cyclically Adjusted Book per Share of $9.59. The current Cyclically Adjusted Book per Share is $9.59. Minerva Neurosciences' overall GF Score™ is 34/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Minerva Neurosciences (NERV), the current Cyclically Adjusted Book per Share is $9.59 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Minerva Neurosciences Business Description

Other Exchanges 4MNA:Germany
Address 1500 District Avenue, Burlington, MA, USA, 01803
Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.
34GF Score

Get the complete analysis for NERV

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.48
Price